CLRB Cellectar BioSciences
- 2.6700
- -0.2300-7.93%
- 2.7299
- +0.0599+2.24%
Cellectar BioSciences News
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer CARUSO JAMES V
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer Longcor Jarrod
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer Kolean Chad J
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer Shustov Andrei
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer Lea Darrell Shane
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Director Chanan-Khan Asher
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Director DRISCOLL FREDERICK W
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Director Loren Stefan
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Director Swirsky Douglas J
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Director NEIS JOHN
Cellectar BioSciences | 8-K: Current report
Cellectar BioSciences | S-3: Registration statement for specified transactions by certain issuers
Cellectar BioSciences | DEFR14A: Definitive proxy statement in connection with contested solicitations
Cellectar BioSciences | 8-K: Current report
Cellectar BioSciences | 10-Q: Quarterly report
Cellectar BioSciences | DEFA14A: Others
Cellectar BioSciences | ARS: Annual Report to Security Holders
Cellectar BioSciences | DEF 14A: Definitive information statements
Cellectar BioSciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rosalind Advisors, Inc.(9.9%),Steven Salamon(9.9%), etc.
Cellectar BioSciences | 10-K/A: Annual report (Amendment)
Analysis
Price Target
No Data
